We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · October 17, 2021

Outcomes of High-Dose Methylprednisolone Pulse Therapy for Moderate to Severe AA

The British Journal of Dermatology


Additional Info

The British Journal of Dermatology
A retrospective study evaluating the outcomes of high-dose methylprednisolone pulse therapy for 483 patients with moderate-to-severe alopecia areata
Br J Dermatol 2021 Jul 13;[EPub Ahead of Print], M Wada-Irimada, M Mizuashi, T Takahashi, G Tojo, K Onami, K Shido, E Otake, S Yusa, K Tanita, E Yamazaki, S Aiba, K Yamasaki

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading